Literature DB >> 19935834

Genome scan for loci regulating HDL cholesterol levels in Finnish extended pedigrees with early coronary heart disease.

Tiia Kangas-Kontio1, Sakari Kakko, Minna Tamminen, Peter von Rohr, Ina Hoeschele, Tatu Juvonen, Juha Kere, Markku J Savolainen.   

Abstract

Coronary heart disease (CHD) is the leading cause of mortality in Western societies. Its risk is inversely correlated with plasma high-density lipoprotein cholesterol (HDL-C) levels, and approximately 50% of the variability in these levels is genetically determined. In this study, the aim was to carry out a whole-genome scan for the loci regulating plasma HDL-C levels in 35 well-defined Finnish extended pedigrees (375 members genotyped) with probands having low HDL-C levels and premature CHD. The additive genetic heritability of HDL-C was 43%. A variance component analysis revealed four suggestive quantitative trait loci (QTLs) for HDL-C levels, with the highest LOD score, 3.1, at the chromosomal locus 4p12. Other suggestive LOD scores were 2.1 at 2q33, 2.1 at 6p24 and 2.0 at 17q25. Three suggestive loci for the qualitative low HDL-C trait were found, with a nonparametric multipoint score of 2.6 at the chromosomal locus 10p15.3, 2.5 at 22q11 and 2.1 at 6p12. After correction for statin use, the strongest evidence of linkage was shown on chromosomes 4p12, 6p24, 6p12, 15q22 and 22q11. To search for the underlying gene on chromosome 6, we analyzed two functional and positional candidate genes (peroxisome proliferator-activated receptor-delta (PPARD), and retinoid X receptor beta, (RXRB)), but found no significant evidence of association. In conclusion, we identified seven chromosomal regions for HDL-C regulation exceeding the level for suggestive evidence of linkage.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19935834      PMCID: PMC2987327          DOI: 10.1038/ejhg.2009.202

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  61 in total

1.  Mega2: data-handling for facilitating genetic linkage and association analyses.

Authors:  Nandita Mukhopadhyay; Lee Almasy; Mark Schroeder; William P Mulvihill; Daniel E Weeks
Journal:  Bioinformatics       Date:  2005-03-03       Impact factor: 6.937

2.  Adjusting for treatment effects in studies of quantitative traits: antihypertensive therapy and systolic blood pressure.

Authors:  Martin D Tobin; Nuala A Sheehan; Katrina J Scurrah; Paul R Burton
Journal:  Stat Med       Date:  2005-10-15       Impact factor: 2.373

3.  Genome scan for quantitative trait loci influencing HDL levels: evidence for multilocus inheritance in familial combined hyperlipidemia.

Authors:  France Gagnon; Gail P Jarvik; Michael D Badzioch; Arno G Motulsky; John D Brunzell; Ellen M Wijsman
Journal:  Hum Genet       Date:  2005-06-16       Impact factor: 4.132

4.  Evidence for a gene influencing high-density lipoprotein cholesterol on chromosome 4q31.21.

Authors:  Zari Dastani; Leigh Quiogue; Christopher Plaisier; James C Engert; Michel Marcil; Jacques Genest; Päivi Pajukanta
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-12-01       Impact factor: 8.311

5.  Magnitude and distribution of linkage disequilibrium in population isolates and implications for genome-wide association studies.

Authors:  Susan Service; Joseph DeYoung; Maria Karayiorgou; J Louw Roos; Herman Pretorious; Gabriel Bedoya; Jorge Ospina; Andres Ruiz-Linares; António Macedo; Joana Almeida Palha; Peter Heutink; Yurii Aulchenko; Ben Oostra; Cornelia van Duijn; Marjo-Riitta Jarvelin; Teppo Varilo; Lynette Peddle; Proton Rahman; Giovanna Piras; Maria Monne; Sarah Murray; Luana Galver; Leena Peltonen; Chiara Sabatti; Andrew Collins; Nelson Freimer
Journal:  Nat Genet       Date:  2006-04-02       Impact factor: 38.330

6.  Genome-wide linkage analyses and candidate gene fine mapping for HDL3 cholesterol: the Framingham Study.

Authors:  Qiong Yang; Chao-Qiang Lai; Laurence Parnell; L Adrienne Cupples; Xian Adiconis; Yueping Zhu; Peter W F Wilson; David E Housman; Amanda M Shearman; Ralph B D'Agostino; Jose M Ordovas
Journal:  J Lipid Res       Date:  2005-04-01       Impact factor: 5.922

Review 7.  Gene mapping in the 20th and 21st centuries: statistical methods, data analysis, and experimental design.

Authors:  J D Terwilliger; H H Göring
Journal:  Hum Biol       Date:  2000-02       Impact factor: 0.553

8.  A genome wide quantitative trait linkage analysis for serum lipids in type 2 diabetes in an African population.

Authors:  Adebowale A Adeyemo; Thomas Johnson; Joseph Acheampong; Johnnie Oli; Godfrey Okafor; Albert Amoah; Samuel Owusu; Kofi Agyenim-Boateng; Benjamin A Eghan; Fayeofori Abbiyesuku; Olufemi Fasanmade; Theresa Rufus; Ayo Doumatey; Guanjie Chen; Jie Zhou; Yuanxiu Chen; Paulette Furbert-Harris; Georgia Dunston; Francis Collins; Charles Rotimi
Journal:  Atherosclerosis       Date:  2005-02-24       Impact factor: 5.162

9.  A novel quantitative trait locus on chromosome 1 with pleiotropic effects on HDL-cholesterol and LDL particle size in hypertensive sibships.

Authors:  Iftikhar J Kullo; Stephen T Turner; Eric Boerwinkle; Sharon L R Kardia; Mariza de Andrade
Journal:  Am J Hypertens       Date:  2005-08       Impact factor: 2.689

10.  Multiple QTLs influencing triglyceride and HDL and total cholesterol levels identified in families with atherogenic dyslipidemia.

Authors:  Yi Yu; Diego F Wyszynski; Dawn M Waterworth; Steven D Wilton; Philip J Barter; Y Antero Kesäniemi; Robert W Mahley; Ruth McPherson; Gérard Waeber; Thomas P Bersot; Qianli Ma; Sanjay S Sharma; Douglas S Montgomery; Lefkos T Middleton; Scott S Sundseth; Vincent Mooser; Scott M Grundy; Lindsay A Farrer
Journal:  J Lipid Res       Date:  2005-08-01       Impact factor: 5.922

View more
  1 in total

1.  Sex-specific association of rs16996148 SNP in the NCAN/CILP2/PBX4 and serum lipid levels in the Mulao and Han populations.

Authors:  Ting-Ting Yan; Rui-Xing Yin; Qing Li; Ping Huang; Xiao-Na Zeng; Ke-Ke Huang; Lynn Htet Htet Aung; Dong-Feng Wu; Cheng-Wu Liu; Shang-Ling Pan
Journal:  Lipids Health Dis       Date:  2011-12-31       Impact factor: 3.876

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.